Inventor · disambiguated record
William A. Petri, Jr.
Also filed as: PETRI JR WILLIAM A · PETRI WILLIAM · PETRI WILLIAM A
14 granted patents·9 pending applications·61 citations·filing 1989–2025
90Inventor score
Files withUNIV VIRGINIA9UNIV VIRGINIA PATENT FOUNDATION9ACCESS TO ADVANCED HEALTH INST2FOX CHRISTOPHER1INFECTIOUS DISEASE RES INST1
Top patents by PatentIndex Score
23 records- 0184US11266602B2PEGylated liposomes and methods of useINFECTIOUS DISEASE RES INST·Filed 2017·Granted Mar 8, 2022·2 cites·21 claims
- 0277US10196453B2Compositions and methods for treating Clostridium difficile infectionUNIV VIRGINIA PATENT FOUNDATION·Filed 2017·Granted Feb 5, 2019·3 cites·9 claims
- 0375US10046030B2Compositions and methods for preventing and treating infectionUNIV VIRGINIA PATENT FOUNDATION·Filed 2015·Granted Aug 14, 2018·2 cites·31 claims
- 0472US12318484B2Pegylated liposomes and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2021·Granted Jun 3, 2025·0 cites·18 claims
- 0563US2025171546A1Dupilumab for treatment of covid-19UNIV VIRGINIA PATENT FOUNDATION·Filed 2023·Application pending·0 cites
- 0663US2025177376A1Alpha 2 adrenergic receptor blockade for the treatment of c. difficile colitisUNIV VIRGINIA PATENT FOUNDATION·Filed 2023·Application pending·0 cites
- 0763US2025241857A1Pegylated liposomes and methods of useACCESS TO ADVANCED HEALTH INST·Filed 2025·Application pending·0 cites
- 0855US2024075055A1Hyaluronan is a driver of covid-19 severityUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 0953US2022378877A1Treatment of clostridium difficile infectionsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 1052US6187310B1Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene familyUNIV VIRGINIA·Filed 1997·Granted Feb 13, 2001·12 cites·22 claims
- 1152US2024180834A1Development of covid-19 vaccine using a dual tlr ligand liposome adjuvantFOX CHRISTOPHER·Filed 2022·Application pending·0 cites
- 1252US2025082716A1Repressed ang 1-7 in covid-19 is inversely associated with inflammation and coagulationUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Application pending·0 cites
- 1350US2023227546A1Type 2 cytokines as predictors of disease severity and/or as therapeutic targets for covid-19UNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 1448US10758591B2Compositions and methods for treating clostridium difficile infectionUNIV VIRGINIA PATENT FOUNDATION·Filed 2017·Granted Sep 1, 2020·0 cites·23 claims
- 1545US5272058ADiagnostic methods for E. histolyticaUNIV VIRGINIA·Filed 1990·Granted Dec 21, 1993·11 cites·55 claims
- 1642US6165469ARecombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kD subunit multigene familyUNIV VIRGINIA·Filed 1994·Granted Dec 26, 2000·4 cites·19 claims
- 1742US5891634ATransfection of enteric parasitesUNIV VIRGINIA·Filed 1996·Granted Apr 6, 1999·8 cites·22 claims
- 1842US5004608AAmebiasis vaccineUNIV VIRGINIA·Filed 1989·Granted Apr 2, 1991·10 cites·5 claims
- 1940US2013130965A1Method to detect and treat infectious or inflammatory diarrhea based on reg1PETRI JR WILLIAM A·Filed 2011·Application pending·0 cites
- 2036US5665565ATransfection of enteric parasitesUNIV VIRGINIA·Filed 1995·Granted Sep 9, 1997·5 cites·26 claims
- 2134US5260429APurified DNA of the 170-kd surface Gal/GalNAc adherence lectin of pathogenic E. histolyticaUNIV VIRGINIA·Filed 1990·Granted Nov 9, 1993·4 cites·1 claims
- 2227US5401831AMonoclonal antibodies for differentiating pathogenic and nonpathogenic E. histolyticaUNIV VIRGINIA·Filed 1993·Granted Mar 28, 1995·0 cites·5 claims
- 2326US5405748ADiagnostic methods for E. histolyticaUNIV VIRGINIA·Filed 1993·Granted Apr 11, 1995·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →